News Hub | News Direct

All Industries


Article thumbnail News Release

Great Republic Mining finishes geophysics program at Porcher Island Property

Great Republic Mining

Great Republic Mining Corporation CEO Fred Davidson joined Steve Darling from Proactive to share the results of the company's 2023 prospecting, sampling, and ground geophysics program on the Porcher Island Vanadium-Titanium-Iron Property in British Columbia. Davidson highlighted that the field program successfully expanded the discoveries of Vanadium mineralization on the Porcher Island Property, which is strategically located on tidewater, just 40 kilometers from the deepwater, all-season port of Prince Rupert. During the program, 30 rock samples were taken, with values ranging up to 0.17% V, equivalent to 0.303% V205. Additionally, the company utilized 2019 airborne magnetic geophysics data, confirming several distinct high magnetic anomalies. Ground magnetics were also conducted, covering 5 line-km in a core area, revealing numerous localized magnetic highs for future exploration. The results from the 2023 field program confirmed the potential for mineralization of a large-scale stratified Vanadium-Iron-Titanium system on the Porcher Island Property. Historic airborne magnetics surveys also highlighted two other areas, measuring 2.5 by 4.5km and 2 by 3km respectively, which were sampled and returned anomalous vanadium values, warranting further follow-up exploration efforts. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 26, 2024 10:44 AM Eastern Standard Time

Video
Article thumbnail News Release

Clearmind Medicine receives Patent Approval in China for treatment of binge behaviours

Clearmind Medicine Inc

Clearmind Medicine Inc CEO Dr. Adi Zuloff-Shani joined Steve Darling from Proactive to announce a significant milestone for the company: the granting of divisional patent approval by the China National Intellectual Property Administration (CNIPA). This latest patent approval solidifies Clearmind's patent protection for its flagship molecule and further establishes its extensive intellectual property (IP) protection in the psychedelic space. Clearmind's IP portfolio now encompasses fifteen utility patent families, including patents and applications with method of use and composition of matter claims. This includes 24 pending patent applications and 27 granted patents in key jurisdictions such as the US, Europe, China, and India. The company's robust IP portfolio positions it as a leader in the development of innovative treatments in the psychedelic field. Dr. Zuloff-Shani provided insights into Clearmind's flagship molecule, MEAI, which has shown promise in reducing the desire to consume alcoholic beverages while inducing a slight euphoric, alcohol-like experience. This treatment targets Alcohol Use Disorder, a prevalent condition characterized by an individual's inability to control their alcohol consumption despite negative consequences. MEAI also holds potential in addressing binge drinking, offering hope for individuals struggling with this harmful addiction. Clearmind plans to commence clinical trials for alcohol use disorder, expand their IP portfolio, and explore M E's potential in treating obesity. With collaborations with esteemed institutions like Johns Hopkins and Yale, Clearmind aims to revolutionize addiction treatment and offer innovative solutions to societal challenges. Stay tuned for their exciting developments in 2024. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 26, 2024 10:37 AM Eastern Standard Time

Video
Article thumbnail News Release

Cardiff Lexington CEO Alex Cunningham Discusses Healthcare Growth Strategy

Cardiff Lexington Corporation

Cardiff Lexington CEO Alex Cunningham joined Steve Darling from Proactive to discuss the company's transformation into an acquisition-oriented healthcare firm with a focus on orthopedic surgery centers. Cardiff Lexington's revenue primarily stems from bodily injury and general liability insurance coverages, providing insulation from pricing downsides associated with Medicare and Medicaid. Cunningham emphasized the unique accounts receivable structure of the company, along with its focus on uninsured coverages, which contribute to maintaining high collectability rates. He also highlighted the increasing demand for orthopedic services driven by an aging population, positioning Cardiff Lexington for growth in this market. The company's recent financial performance showed significant increases in revenue, net earnings, and assets, reflecting its strategic focus and operational efficiency. Looking ahead to 2024, Cardiff Lexington plans to continue its expansion through acquisitions, market expansion initiatives, and strategic partnerships. Furthermore, Cunningham mentioned the company's plans to release its 10k in early March and pursue an uplift to a major exchange in 2024, with a clear focus on enhancing shareholder value and achieving strategic growth objectives. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 26, 2024 10:32 AM Eastern Standard Time

Video
Article thumbnail News Release

Metal Energy Corp announces downhole geophysical work identifies two Brine reservoirs

Metal Energy Corp

Metal Energy Corp CEO James Sykes joined Steve Darling from Proactive to share exciting developments regarding the company's SourceRock lithium brine project near Thunder Bay, Ontario. The project, situated in the Thunder Bay-Nipigon area of northwestern Ontario, spans an expansive area of 915 square kilometers, making it highly prospective for lithium brines. Sykes revealed that a downhole geophysical survey conducted by the company has identified two distinct brine reservoirs in drill hole SR-24-01. The upper zone, ranging from 151 meters to 165 meters, and the lower zone, extending from 474 meters to 520 meters, show promising lithium potential. Importantly, these reservoirs are believed to be stratigraphically continuous with a historic drill hole, BSW-06-04A, located just 5 kilometers away. Of particular significance is the lower zone, which exhibits fluid conductivities at least twice that of seawater, indicating the presence of highly saline brines. Scientific research suggests that highly saline brines often contain elevated concentrations of lithium, making them attractive targets for lithium extraction. Metals Energy Corp's identification of these brine reservoirs marks a significant milestone in the development of the SourceRock project. The company is now positioned to further explore and evaluate the lithium potential of these reservoirs, with the goal of advancing towards commercial production. As demand for lithium continues to rise, particularly in the electric vehicle and renewable energy sectors, Metals Energy Corp is well-positioned to capitalize on the growing market opportunity. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 26, 2024 10:26 AM Eastern Standard Time

Video
Article thumbnail News Release

Doubleview Gold Corp latest assays shows expansion at South Lisle Zone at Hat Project

Doubleview Gold Corp

Doubleview Gold Corp CEO Farshad Shirvani joined Steve Darling from Proactive to share significant insights from the analyses of three drill holes at the Hat Property, located in the Stikine mining district of northwestern British Columbia. The 2023 drilling program focused on exploring and confirming the southern and southwestern extensions of the Lisle zone of porphyry-style mineralization. The results revealed robust metal values and broad dimensions, uncovering a previously undisclosed area rich in gold and cobalt. Shirvani emphasized that the latest drill holes validate the dimensions of the Hat deposit and underscore the consistent presence of strong values in copper, gold, cobalt, silver, and scandium. These metals are essential components in emerging technologies aimed at supplementing or replacing traditional energy sources, aligning with the global push for sustainable energy solutions. The assay data from an additional five drill holes is eagerly anticipated and will be released as soon as it is confirmed. These forthcoming results are expected to provide further insights into the extent and richness of mineralization at the Hat Property, bolstering Doubleview Gold Corp's position as a key player in the exploration and development of metals critical to advancing modern technologies. As the company continues its exploration efforts and analyzes additional drill results, investors can expect continued updates that highlight the potential of the Hat Property and its significance in meeting the growing demand for metals essential to a sustainable future. Stay tuned for further developments from Doubleview Gold Corp as they advance their exploration initiatives and unlock the full potential of their mining assets. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 26, 2024 10:21 AM Eastern Standard Time

Video
Article thumbnail News Release

Grayscale's New ETF To Track Zcash, THORChain Price Dips, KangaMoon Soars

Kangamoon

Grayscale wants to introduce a new ETF to track privacy-based coins like Zcash. In other news, THORChain price has dropped, forcing investors to buy KangaMoon. KangaMoon has shown bullish momentum in the past week, skyrocketing 50%, making it the best coin to invest in. Grayscale Working on New ETF To Track Privacy-based Coins Like Zcash (ZEC) Grayscale Investments has told the U.S. Securities and Exchange Commission (SEC) its plan to launch a novel ETF, the Grayscale Privacy ETF (PRVC), focusing on the data privacy sector. This ETF will dedicate over 80% of its assets to companies specializing in data privacy solutions and blockchain-based privacy technologies, including protocols such as Zcash (ZEC). While PRVC will not hold cryptocurrencies directly, it will mirror the Indxx Data Privacy Index. Additionally, Grayscale plans to invest about 10% of its assets in privacy-centric protocols through ZCSH, Grayscale's Zcash Trust. Meanwhile, Zcash is one of the altcoins that has been banned by most centralized exchanges. Yet, the token has managed to maintain a bullish price movement in the past week. Its price has increased 20.7% to a peak of $29.26 from a 7-day low of $22.29. THORChain (RUNE) Price Drops 15.6% THORChain (RUNE), the native token of a decentralized exchange (DEX) that supports cross-chain swaps, has dropped into the red region. A look at its price chart shows that bears are leading the market on the weekly timeframe. They have pushed the price of THORChain down 15.6% from a peak of $5.88 to a low of $4.97. Nevertheless, THORChain RUNE joins other altcoins that are bullish on the monthly and yearly timeframes, with an increase of 23.1% and 191.7%, respectively. Therefore, the token still has a chance to clear the losses on the weekly chart. THORChain's technical indicators show that it is trading above the 50-day SMA ($4.60) and 200-day SMA ($3.47). As a result, analysts predict that THORChain will rise by 32.03% and reach $6.60 soon. KangaMoon (KANG) Stage 2 Selling Fast The crypto community's growing interest in meme coins with real utility has pushed investors towards KangaMoon (KANG). KangaMoon, a project still in its blockchain ICO, seeks to redefine meme coins by adding utility to them. It is building a community-centric space that merges Social-Fi elements with competitive gaming to reward participation and in-game achievements. KANG token holders stand to benefit significantly, with numerous opportunities to earn additional tokens through contests and competitions. These tokens not only serve as the platform's primary currency but also play a crucial role in its ecosystem, facilitating various transactions and activities. The blockchain ICO's stage 2 has already seen high interest, raising about $67,250, and its selling out rapidly where each token is priced at $0.0075. With the play-to-earn gaming market's value at $885M in 2023 and expected to grow, KangaMoon is poised for huge growth. Also, analysts are anticipating further price increases, making this the best time to get involved before it moves to the next stage. Conclusion While THORChain is grappling with bearish pressure in the market, KangaMoon has reached a new peak of $0.0075. Still, analysts see KangaMoon rising to higher heights in the coming weeks, making it the best coin to invest in right now. Discover the Exciting Opportunities of the KangaMoon (KANG) Presale Today! Website: https://Kangamoon.com/ Join Our Telegram Community: https://t.me/Kangamoonofficial Integrating GameFi and Play To EarnEmbark on your quest for glory. Assemble your champions, engage in epic battles or bet on your favorite fighters to earn $KANG tokens and exclusive rewards. Gain control of rare NFTs, unlock exclusive content and build alliances with fellow gamers as you ascend the ranks and leaderboards. Contact Details Kangamoon marketing@kangamoon.com Company Website https://kangamoon.com/

February 26, 2024 09:00 AM Central Standard Time

Image
Article thumbnail News Release

Jubilee Metals reports strong first-half performance across all operations; eyes future growth

Jubilee Metals Group PLC

Jubilee Metals Group (AIM:JLP, JSE:JBL, OTC:JUBPF) CEO Leon Coetzer shares insights into the company's positive performance in the first half of the year in an interview with Proactive's Stephen Gunnion. Despite pressure on platinum group metals (PGM) prices, Jubilee Metals experienced a robust operational and financial performance. Coetzer attributed this to a strategic shift towards focusing on chrome and copper production in South Africa and Zambia, respectively. The company has seen significant growth in operational output and an increase in the margin per tonne of chrome. Copper production is also on the rise, with the Roan concentrator upgrade expected to significantly boost copper output. Coetzer said Jubilee Metals remained profitable due to its diversified portfolio in critical metals and is well-positioned to benefit from any recovery in PGM prices. Coetzer highlighted a 47% increase in copper cathode and concentrate production over the half-year and discussed the impact of the Roan concentrator, which is expected to more than double current production. Additionally, a partnership with International Resources Holding (IRH) from Abu Dhabi aims to further expand copper production in Zambia by leveraging the company's processing capabilities to target underutilized resources. The company's balance sheet is healthy, bolstered by a £13 million oversubscribed capital raise in January. Coetzer noted that Jubilee Metals' operations in South Africa are self-funding and cash flow positive, allowing for reinvestment into the company's growth. The strategic use of modular plant rollouts in Zambia is expected to follow a similar financially positive trajectory. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 26, 2024 09:57 AM Eastern Standard Time

Video
Article thumbnail News Release

Ondo InsurTech partners with South West Water to tackle UK water scarcity; inks new US LeakBot deal

Ondo InsurTech PLC

Ondo InsurTech PLC (LSE:ONDO) CEO Craig Foster joins Proactive's Stephen Gunnion with news the company has partnered with South West Water to deploy 6,000 LeakBots in a water-stressed region in the UK to reduce leaks, marking its third collaboration with a UK water company. This initiative is part of a broader effort to address water scarcity in the UK, exacerbated by climate change and population growth. Foster highlighted that 8% of UK toilets leak, wasting significant amounts of water daily. Ondo InsurTech's LeakBot solution allows homeowners to easily install a device that detects leaks, enabling timely repairs. In the US, Ondo InsurTech is expanding its footprint, inking a deal with Selective Insurance, the US property and casualty group, which will offer its LeakBot, a self-install leak detection unit, to policyholders. The company has now signed agreements with four major insurers in the past nine months, including a significant partnership with Nationwide. These deals demonstrate the company's growing momentum in the US market, where insurers spend around $16 billion annually on water leak damages. Foster also mentioned Ondo InsurTech's nomination for the Breakthrough of the Year Award at the 2023 PLC Awards, competing against giants like Rolls Royce. Despite considering its chances slim, Foster sees the nomination as an honour and an indication of the company's innovative impact in addressing water conservation and leak prevention. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 26, 2024 09:53 AM Eastern Standard Time

Video
Article thumbnail News Release

IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025

IQ-AI Ltd

Dr Jennifer Connelly, MD, the Principal Investigator (PI) of the IQ-AI Limited sponsored phase one clinical trial that is being conducted at the Medical College of Wisconsin, joined Proactive's Stephen Gunnion with a positive update from its treatment for recurring glioblastoma patients. Connelly explained that glioblastoma, the most common malignant brain tumour, significantly impacts brain function, highlighting the importance of clinical trials to improve patient quality of life. The trial, opened nearly two years ago, investigates gallium maltolate, an oral medication showing promise in preclinical studies and animal models for efficacy against tumour cells. This phase focuses on drug tolerance, with patients reporting ease of use compared to traditional treatments and the ability to maintain normal daily activities. An expanded access programme (EAP), also known as compassionate use, has been launched by IA-AI subsidiary Imaging Biometric to allow wider access to gallium maltolate across the country, benefiting patients unable to travel to the Medical College of Wisconsin. The EAP, approved by the FDA, aims to collect additional safety and toxicity data, contributing to the trial's findings and supporting the progression towards a phase two clinical trial. The next milestone, by the end of 2024, involves concluding the phase one trial, determining the maximum tolerated dose, and preparing for the phase two trial slated for 2025, focusing on safety and beginning to evaluate efficacy. Contact Details Proactive UK Proactive UK +44 20 7989 0813 UKEditorial@proactiveinvestors.com

February 26, 2024 09:51 AM Eastern Standard Time

Video
1 ... 403404405406407 ... 3767